Cargando…
Cannabinoids as an Alternative Option for Conventional Analgesics in Cancer Pain Management: A Pharmacogenomics Perspective
The global cancer burden is significantly increasing at an alarming rate affecting patients, relatives, communities, and health-care system. Cancer patients require adequate pain relief and palliative care throughout the life course, especially in terminal illness. Although opioid treatment is succe...
Autores principales: | Jose, Anmi, Thomas, Levin, Baburaj, Gayathri, Munisamy, Murali, Rao, Mahadev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017683/ https://www.ncbi.nlm.nih.gov/pubmed/32132797 http://dx.doi.org/10.4103/IJPC.IJPC_155_19 |
Ejemplares similares
-
Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021) -
Signet ring cell cancer of stomach and gastro-esophageal junction: molecular alterations, stage-stratified treatment approaches, and future challenges
por: Kumar, Naveena A. N., et al.
Publicado: (2021) -
Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers
por: Kolesar, Jill, et al.
Publicado: (2022) -
Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
por: Jose, Anmi, et al.
Publicado: (2020) -
Pharmacogenomics in Palliative Medicine
por: Rao, Mahadev
Publicado: (2019)